ClinicalTrials.gov record
A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
ClinicalTrials.gov ID: NCT00441558
Public ClinicalTrials.gov record NCT00441558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Worldwide One-year Open-label Safety Study of Flibanserin in Women With HSDD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine if long-term treatment with Flibanserin is safe and to monitor the effectiveness of Flibanserin in Women with HSDD that have already completed a previous study (511.70/71/.74/.75/.105) with Flibanserin.
Study identification
- NCT ID
- NCT00441558
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,723 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2007 (Type not available)
- Primary completion
- Aug 2009 (Actual)
- Completion
- Aug 2009 (Actual)
- Last update posted
- Jun 13, 2014
2007 – 2009
United States locations
- U.S. sites
- 173
- U.S. states
- 41
- U.S. cities
- 133
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 511.84.01079 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 511.84.01193 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 511.84.01188 Boehringer Ingelheim Investigational Site | Huntsville | Alabama | — | — |
| 511.84.01110 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 511.84.01142 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 511.84.01157 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 511.84.01162 Boehringer Ingelheim Investigational Site | Little Rock | Alaska | — | — |
| 511.84.01070 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 511.84.01191 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 511.84.01115 Boehringer Ingelheim Investigational Site | Tucson | Arizona | — | — |
| 511.84.01013 Boehringer Ingelheim Investigational Site | Jonesboro | Arkansas | — | — |
| 511.84.01087 Boehringer Ingelheim Investigational Site | Berkeley | California | — | — |
| 511.84.01077 Boehringer Ingelheim Investigational Site | Encinitas | California | — | — |
| 511.84.01074 Boehringer Ingelheim Investigational Site | Fair Oaks | California | — | — |
| 511.84.01104 Boehringer Ingelheim Investigational Site | Irvine | California | — | — |
| 511.84.01037 Boehringer Ingelheim Investigational Site | La Jolla | California | — | — |
| 511.84.01056 Boehringer Ingelheim Investigational Site | Sacramento | California | — | — |
| 511.84.01195 Boehringer Ingelheim Investigational Site | Sacramento | California | — | — |
| 511.84.01043 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 511.84.01047 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 511.84.01096 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 511.84.01040 Boehringer Ingelheim Investigational Site | Stanford | California | — | — |
| 511.84.01048 Boehringer Ingelheim Investigational Site | Tarzana | California | — | — |
| 511.84.01017 Boehringer Ingelheim Investigational Site | Torrance | California | — | — |
| 511.84.01173 Boehringer Ingelheim Investigational Site | Vista | California | — | — |
| 511.84.01029 Boehringer Ingelheim Investigational Site | Walnut Creek | California | — | — |
| 511.84.01137 Boehringer Ingelheim Investigational Site | Westlake Village | California | — | — |
| 511.84.01090 Boehringer Ingelheim Investigational Site | Aurora | Colorado | — | — |
| 511.84.01164 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 511.84.01184 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 511.84.01004 Boehringer Ingelheim Investigational Site | Englewood | Colorado | — | — |
| 511.84.01006 Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| 511.84.01138 Boehringer Ingelheim Investigational Site | Farmington | Connecticut | — | — |
| 511.84.01044 Boehringer Ingelheim Investigational Site | Groton | Connecticut | — | — |
| 511.84.01016 Boehringer Ingelheim Investigational Site | Hartford | Connecticut | — | — |
| 511.84.01108 Boehringer Ingelheim Investigational Site | New Britain | Connecticut | — | — |
| 511.84.01168 Boehringer Ingelheim Investigational Site | New London | Connecticut | — | — |
| 511.84.01166 Boehringer Ingelheim Investigational Site | Newark | Delaware | — | — |
| 511.84.01160 Boehringer Ingelheim Investigational Site | Washington D.C. | District of Columbia | — | — |
| 511.84.01065 Boehringer Ingelheim Investigational Site | Aventura | Florida | — | — |
| 511.84.01005 Boehringer Ingelheim Investigational Site | Boynton Beach | Florida | — | — |
| 511.84.01146 Boehringer Ingelheim Investigational Site | Clearwater | Florida | — | — |
| 511.84.01144 Boehringer Ingelheim Investigational Site | Coral Gables | Florida | — | — |
| 511.84.01169 Boehringer Ingelheim Investigational Site | Daytona Beach | Florida | — | — |
| 511.84.01085 Boehringer Ingelheim Investigational Site | Fort Lauderdale | Florida | — | — |
| 511.84.01194 Boehringer Ingelheim Investigational Site | Fort Meyers | Florida | — | — |
| 511.84.01002 Boehringer Ingelheim Investigational Site | Gainesville | Florida | — | — |
| 511.84.01069 Boehringer Ingelheim Investigational Site | Gainsville | Florida | — | — |
| 511.84.01007 Boehringer Ingelheim Investigational Site | Hudson | Florida | — | — |
| 511.84.01055 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 511.84.01064 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 511.84.01182 Boehringer Ingelheim Investigational Site | New Port Richey | Florida | — | — |
| 511.84.01167 Boehringer Ingelheim Investigational Site | Ocala | Florida | — | — |
| 511.84.01111 Boehringer Ingelheim Investigational Site | Orlando | Florida | — | — |
| 511.84.01118 Boehringer Ingelheim Investigational Site | Orlando | Florida | — | — |
| 511.84.01135 Boehringer Ingelheim Investigational Site | Pembroke Pines | Florida | — | — |
| 511.84.01032 Boehringer Ingelheim Investigational Site | Plantation | Florida | — | — |
| 511.84.01175 Boehringer Ingelheim Investigational Site | Sarasota | Florida | — | — |
| 511.84.01053 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 511.84.01132 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 511.84.01117 Boehringer Ingelheim Investigational Site | Stuart | Florida | — | — |
| 511.84.01159 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 511.84.01170 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 511.84.01183 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 511.84.01003 Boehringer Ingelheim Investigational Site | West Palm Beach | Florida | — | — |
| 511.84.01022 Boehringer Ingelheim Investigational Site | West Palm Beach | Florida | — | — |
| 511.84.01024 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 511.84.01061 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 511.84.01205 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 511.84.01176 Boehringer Ingelheim Investigational Site | Marietta | Georgia | — | — |
| 511.84.01139 Boehringer Ingelheim Investigational Site | Roswell | Georgia | — | — |
| 511.84.01023 Boehringer Ingelheim Investigational Site | Sandy Springs | Georgia | — | — |
| 511.84.01179 Boehringer Ingelheim Investigational Site | Champaign | Illinois | — | — |
| 511.84.01113 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 511.84.01165 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 511.84.01172 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 511.84.01143 Boehringer Ingelheim Investigational Site | Evansville | Indiana | — | — |
| 511.84.01092 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 511.84.01202 Boehringer Ingelheim Investigational Site | Wichita | Kansas | — | — |
| 511.84.01049 Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 511.84.01025 Boehringer Ingelheim Investigational Site | Baton Rouge | Louisiana | — | — |
| 511.84.01171 Boehringer Ingelheim Investigational Site | Lafayette | Louisiana | — | — |
| 511.84.01192 Boehringer Ingelheim Investigational Site | New Orleans | Louisiana | — | — |
| 511.84.01130 Boehringer Ingelheim Investigational Site | New Orlean | Louisiana | — | — |
| 511.84.01001 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 511.84.01120 Boehringer Ingelheim Investigational Site | Brighton | Massachusetts | — | — |
| 511.84.01030 Boehringer Ingelheim Investigational Site | Haverhill | Massachusetts | — | — |
| 511.84.01127 Boehringer Ingelheim Investigational Site | Ann Arbor | Michigan | — | — |
| 511.84.01081 Boehringer Ingelheim Investigational Site | Bingham Farms | Michigan | — | — |
| 511.84.01147 Boehringer Ingelheim Investigational Site | Bingham Farms | Michigan | — | — |
| 511.84.01041 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 511.84.01131 Boehringer Ingelheim Investigational Site | Chaska | Minnesota | — | — |
| 511.84.01128 Boehringer Ingelheim Investigational Site | Chesterfield | Missouri | — | — |
| 511.84.01051 Boehringer Ingelheim Investigational Site | Kansas City | Missouri | — | — |
| 511.84.01034 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 511.84.01042 Boehringer Ingelheim Investigational Site | Billings | Montana | — | — |
| 511.84.01156 Boehringer Ingelheim Investigational Site | Omaha | Nebraska | — | — |
| 511.84.01148 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 511.84.01206 Boehringer Ingelheim Investigational Site | Moorestown | New Jersey | — | — |
| 511.84.01010 Boehringer Ingelheim Investigational Site | New Brunswick | New Jersey | — | — |
| 511.84.01045 Boehringer Ingelheim Investigational Site | Albequerque | New Mexico | — | — |
| 511.84.01050 Boehringer Ingelheim Investigational Site | Endwell | New York | — | — |
| 511.84.01066 Boehringer Ingelheim Investigational Site | Poughkeepsie | New York | — | — |
| 511.84.01187 Boehringer Ingelheim Investigational Site | Purchase | New York | — | — |
| 511.84.01038 Boehringer Ingelheim Investigational Site | Rochester | New York | — | — |
| 511.84.01059 Boehringer Ingelheim Investigational Site | The Bronx | New York | — | — |
| 511.84.01178 Boehringer Ingelheim Investigational Site | Chapel Hill | North Carolina | — | — |
| 511.84.01121 Boehringer Ingelheim Investigational Site | New Bern | North Carolina | — | — |
| 511.84.01119 Boehringer Ingelheim Investigational Site | Raleigh | North Carolina | — | — |
| 511.84.01072 Boehringer Ingelheim Investigational Site | Winston-Salem | North Carolina | — | — |
| 511.84.01106 Boehringer Ingelheim Investigational Site | Beachwood | Ohio | — | — |
| 511.84.01008 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 511.84.01062 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 511.84.01089 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 511.84.01197 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 511.84.01201 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 511.84.01009 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 511.84.01014 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 511.84.01152 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 511.84.01136 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 511.84.01149 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 511.84.01151 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 511.84.01150 Boehringer Ingelheim Investigational Site | Dayton | Ohio | — | — |
| 511.84.01190 Boehringer Ingelheim Investigational Site | Oklahoma City | Oklahoma | — | — |
| 511.84.01112 Planned Parenthood of Arkansas & Estrn Oklahoma, Inc | Tulsa | Oklahoma | — | — |
| 511.84.01185 Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | — | — |
| 511.84.01019 Boehringer Ingelheim Investigational Site | Eugene | Oregon | — | — |
| 511.84.01134 Boehringer Ingelheim Investigational Site | Medfod | Oregon | — | — |
| 511.84.01103 Boehringer Ingelheim Investigational Site | Portland | Oregon | — | — |
| 511.84.01088 Boehringer Ingelheim Investigational Site | Jenkintown | Pennsylvania | — | — |
| 511.84.01067 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 511.84.01153 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 511.84.01145 Boehringer Ingelheim Investigational Site | Pittsburgh | Pennsylvania | — | — |
| 511.84.01054 Boehringer Ingelheim Investigational Site | West Reading | Pennsylvania | — | — |
| 511.84.01021 Boehringer Ingelheim Investigational Site | Wilkes-Barre | Pennsylvania | — | — |
| 511.84.01060 Boehringer Ingelheim Investigational Site | Warwick | Rhode Island | — | — |
| 511.84.01063 Boehringer Ingelheim Investigational Site | Anderson | South Carolina | — | — |
| 511.84.01124 Boehringer Ingelheim Investigational Site | Columbia | South Carolina | — | — |
| 511.84.01123 Boehringer Ingelheim Investigational Site | Greenville | South Carolina | — | — |
| 511.84.01109 Boehringer Ingelheim Investigational Site | Mt. Pleasant | South Carolina | — | — |
| 511.84.01174 Boehringer Ingelheim Investigational Site | Germantown | Tennessee | — | — |
| 511.84.01163 Boehringer Ingelheim Investigational Site | Knoxville | Tennessee | — | — |
| 511.84.01026 Boehringer Ingelheim Investigational Site | Nashville | Tennessee | — | — |
| 511.84.01100 Boehringer Ingelheim Investigational Site | Nashville | Tennessee | — | — |
| 511.84.01078 Boehringer Ingelheim Investigational Site | Austin | Texas | — | — |
| 511.84.01052 Boehringer Ingelheim Investigational Site | Corpus Christi | Texas | — | — |
| 511.84.01027 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 511.84.01140 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 511.84.01084 Boehringer Ingelheim Investigational Site | Fort Worth | Texas | — | — |
| 511.84.01057 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 511.84.01082 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 511.84.01198 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 511.84.01036 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 511.84.01071 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 511.84.01083 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 511.84.01086 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 511.84.01098 Boehringer Ingelheim Investigational Site | Waco | Texas | — | — |
| 511.84.01015 Boehringer Ingelheim Investigational Site | Salt Lake City | Utah | — | — |
| 511.84.01180 Boehringer Ingelheim Investigational Site | Sandy City | Utah | — | — |
| 511.84.01028 Boehringer Ingelheim Investigational Site | Burlington | Vermont | — | — |
| 511.84.01031 Boehringer Ingelheim Investigational Site | Charlottesville | Virginia | — | — |
| 511.84.01035 Boehringer Ingelheim Investigational Site | Charlottesville | Virginia | — | — |
| 511.84.01107 Boehringer Ingelheim Investigational Site | Norfolk | Virginia | — | — |
| 511.84.01125 Boehringer Ingelheim Investigational Site | Norfolk | Virginia | — | — |
| 511.84.01076 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 511.84.01097 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 511.84.01196 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 511.84.01093 Boehringer Ingelheim Investigational Site | Bellevue | Washington | — | — |
| 511.84.01141 Boehringer Ingelheim Investigational Site | Renton | Washington | — | — |
| 511.84.01012 Boehringer Ingelheim Investigational Site | Seattle | Washington | — | — |
| 511.84.01116 Boehringer Ingelheim Investigational Site | Spokane | Washington | — | — |
| 511.84.01105 Boehringer Ingelheim Investigational Site | Tacoma | Washington | — | — |
| 511.84.01177 Boehringer Ingelheim Investigational Site | Middleton | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00441558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2014 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00441558 live on ClinicalTrials.gov.